Paul Auwaerter, MD, an expert in Lyme disease, explains the importance of raising awareness about Lyme neuroborreliosis, to better improve diagnosis and treatment.
Your search for major depressive disorder returned 11 results
Active Filters
Click on a filter below to refine your search. Remove a filter to broaden your search.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
Lavanya Visvabharathy, PhD, Anna Cervantes-Arslanian, MD, and Jonathan Rogers, PhD, provide a closer look into the phenomenon known as “long-haul COVID” and its potential neurologic effects.
While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.
When combined with other serotonergic agents, selective serotonin reuptake inhibitors can lead to a potentially fatal condition called serotonin syndrome, the incidence of which is likely underestimated.
Perhaps it is that tension between undeniable differences and inevitable merging that has led to more recent calls for cross-disciplinary cooperation.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
-
Latest News Your top articles for Tuesday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses